<noframes id="f9jt9"><form id="f9jt9"><th id="f9jt9"></th></form>
<noframes id="f9jt9">

<form id="f9jt9"><th id="f9jt9"><th id="f9jt9"></th></th></form>
<span id="f9jt9"><span id="f9jt9"><th id="f9jt9"></th></span></span>

<span id="f9jt9"><span id="f9jt9"><track id="f9jt9"></track></span></span>
    <address id="f9jt9"></address>

    <address id="f9jt9"></address><noframes id="f9jt9"><span id="f9jt9"></span>
    <noframes id="f9jt9"><address id="f9jt9"><listing id="f9jt9"><meter id="f9jt9"></meter></listing></address>

    R&D Achievements

    As of December 2018, Consun has accumulatively obtained 37 patent authorizations, including 12 international patents and has published more than 100 academic papers, including 20 in SCI. It has undertaken 40 national, provincial and municipal scientific and technological research projects, and its development of new drugs for diabetic kidney disease has been funded by the National Major New Drug Creation project in 2017. The patents of Yishen Huashi Particles and Bone-setting Liquid were awarded the 18th and 19th China Patent Excellence Awards respectively.

    正规彩票 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>